The Filings Report

Universal Health Services, Inc. Class B

UHSNYSECIK 352915Healthcare / Healthcare Providers & Servicesfiscal year ends December70 quarters since 2009

Revenue, Q3 FY2026
$4.7B
+5.3% on Q3 FY2025
Net income
$309M
−17.2% on Q3 FY2025
Free cash flow
$422M
+177.8% on Q3 FY2025
Diluted EPS
$5.22
−10.9% on Q3 FY2025
Revenue, TTM
$18.4B
trailing four quarters
Net margin, TTM
8.0%
net income $1.5B
Free cash flow, TTM
$1.1B
$2.1B less $941M capex
Cash and equivalents
$169M
long-term debt $5.6B, Sep 30, 2026
Shares, 12-month change
−7.1%
59M diluted weighted shares (no single count on the cover), Sep 30, 2026
Buybacks, TTM
$1.1B
9.4% of market value
Dividends, TTM
$49M
0.4% of market value
Market value
$11.6B
at the close, buybacks

Latest quarter Q3 FY2026, filed November 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Universal Health Services, Inc. Class B reported revenue of $4.7B, +5.3% on Q3 FY2025, and net income of $309M (−17.2%). Operating margin was 9.6%. Free cash flow, operating cash flow less capital expenditures, was $422M ($637M less $215M). Diluted earnings per share were $5.22.

Share price

Daily candlesticks from November 11, 2024 to November 6, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

UHS daily priceSplit-adjusted, US dollars; an earnings release
Nov 6, 2026O $192.56 · H $196.73 · L $191.12 · C $195.50 · −1.56% on the dayOver the range: −13.64%, Nov 7, 2025 to Nov 6, 2026
$134$163$193$223$253Nov 25Jan 26Apr 26Jun 26Aug 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of November 6, 2026.

Revenue and net incomeRevenueNet income
$0$2B$4B$6BQ4'22, Revenue: $3.4BQ4'22, Net income: $175MQ4'22Q1'23, Revenue: $3.5BQ1'23, Net income: $163MQ1'23Q2'23, Revenue: $3.5BQ2'23, Net income: $171MQ2'23Q3'23, Revenue: $3.6BQ3'23, Net income: $167MQ3'23Q4'23, Revenue: $3.7BQ4'23, Net income: $216MQ4'23Q1'24, Revenue: $3.8BQ1'24, Net income: $262MQ1'24Q2'24, Revenue: $3.9BQ2'24, Net income: $289MQ2'24Q3'24, Revenue: $4.0BQ3'24, Net income: $259MQ3'24Q4'24, Revenue: $4.1BQ4'24, Net income: $332MQ4'24Q1'25, Revenue: $4.1BQ1'25, Net income: $317MQ1'25Q2'25, Revenue: $4.3BQ2'25, Net income: $353MQ2'25Q3'25, Revenue: $4.5BQ3'25, Net income: $373MQ3'25Q4'25, Revenue: $4.5BQ4'25, Net income: $446MQ4'25Q1'26, Revenue: $4.5BQ1'26, Net income: $349MQ1'26Q2'26, Revenue: $4.6BQ2'26, Net income: $358MQ2'26Q3'26, Revenue: $4.7BQ3'26, Net income: $309MQ3'26$0$2B$4B$6BQ4'22, Revenue: $3.4BQ4'22, Net income: $175MQ4'22Q1'23, Revenue: $3.5BQ1'23, Net income: $163MQ1'23Q2'23, Revenue: $3.5BQ2'23, Net income: $171MQ2'23Q3'23, Revenue: $3.6BQ3'23, Net income: $167MQ3'23Q4'23, Revenue: $3.7BQ4'23, Net income: $216MQ4'23Q1'24, Revenue: $3.8BQ1'24, Net income: $262MQ1'24Q2'24, Revenue: $3.9BQ2'24, Net income: $289MQ2'24Q3'24, Revenue: $4.0BQ3'24, Net income: $259MQ3'24Q4'24, Revenue: $4.1BQ4'24, Net income: $332MQ4'24Q1'25, Revenue: $4.1BQ1'25, Net income: $317MQ1'25Q2'25, Revenue: $4.3BQ2'25, Net income: $353MQ2'25Q3'25, Revenue: $4.5BQ3'25, Net income: $373MQ3'25Q4'25, Revenue: $4.5BQ4'25, Net income: $446MQ4'25Q1'26, Revenue: $4.5BQ1'26, Net income: $349MQ1'26Q2'26, Revenue: $4.6BQ2'26, Net income: $358MQ2'26Q3'26, Revenue: $4.7BQ3'26, Net income: $309MQ3'26$0$2B$4B$6BQ4'22, Revenue: $3.4BQ4'22, Net income: $175MQ1'23, Revenue: $3.5BQ1'23, Net income: $163MQ1'23Q2'23, Revenue: $3.5BQ2'23, Net income: $171MQ3'23, Revenue: $3.6BQ3'23, Net income: $167MQ3'23Q4'23, Revenue: $3.7BQ4'23, Net income: $216MQ1'24, Revenue: $3.8BQ1'24, Net income: $262MQ1'24Q2'24, Revenue: $3.9BQ2'24, Net income: $289MQ3'24, Revenue: $4.0BQ3'24, Net income: $259MQ3'24Q4'24, Revenue: $4.1BQ4'24, Net income: $332MQ1'25, Revenue: $4.1BQ1'25, Net income: $317MQ1'25Q2'25, Revenue: $4.3BQ2'25, Net income: $353MQ3'25, Revenue: $4.5BQ3'25, Net income: $373MQ3'25Q4'25, Revenue: $4.5BQ4'25, Net income: $446MQ1'26, Revenue: $4.5BQ1'26, Net income: $349MQ1'26Q2'26, Revenue: $4.6BQ2'26, Net income: $358MQ3'26, Revenue: $4.7BQ3'26, Net income: $309MQ3'26

Net income losses drawn in red.

Free cash flow
−$200M$0$200M$400M$600MQ4'22, Free cash flow: $133MQ4'22Q1'23, Free cash flow: $122MQ1'23Q2'23, Free cash flow: $195MQ2'23Q3'23, Free cash flow: −$38MQ3'23Q4'23, Free cash flow: $246MQ4'23Q1'24, Free cash flow: $188MQ1'24Q2'24, Free cash flow: $438MQ2'24Q3'24, Free cash flow: $85MQ3'24Q4'24, Free cash flow: $412MQ4'24Q1'25, Free cash flow: $121MQ1'25Q2'25, Free cash flow: $283MQ2'25Q3'25, Free cash flow: $152MQ3'25Q4'25, Free cash flow: $293MQ4'25Q1'26, Free cash flow: $184MQ1'26Q2'26, Free cash flow: $216MQ2'26Q3'26, Free cash flow: $422MQ3'26−$200M$0$200M$400M$600MQ4'22, Free cash flow: $133MQ4'22Q1'23, Free cash flow: $122MQ1'23Q2'23, Free cash flow: $195MQ2'23Q3'23, Free cash flow: −$38MQ3'23Q4'23, Free cash flow: $246MQ4'23Q1'24, Free cash flow: $188MQ1'24Q2'24, Free cash flow: $438MQ2'24Q3'24, Free cash flow: $85MQ3'24Q4'24, Free cash flow: $412MQ4'24Q1'25, Free cash flow: $121MQ1'25Q2'25, Free cash flow: $283MQ2'25Q3'25, Free cash flow: $152MQ3'25Q4'25, Free cash flow: $293MQ4'25Q1'26, Free cash flow: $184MQ1'26Q2'26, Free cash flow: $216MQ2'26Q3'26, Free cash flow: $422MQ3'26−$200M$0$200M$400M$600MQ4'22, Free cash flow: $133MQ1'23, Free cash flow: $122MQ1'23Q2'23, Free cash flow: $195MQ3'23, Free cash flow: −$38MQ3'23Q4'23, Free cash flow: $246MQ1'24, Free cash flow: $188MQ1'24Q2'24, Free cash flow: $438MQ3'24, Free cash flow: $85MQ3'24Q4'24, Free cash flow: $412MQ1'25, Free cash flow: $121MQ1'25Q2'25, Free cash flow: $283MQ3'25, Free cash flow: $152MQ3'25Q4'25, Free cash flow: $293MQ1'26, Free cash flow: $184MQ1'26Q2'26, Free cash flow: $216MQ3'26, Free cash flow: $422MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$2B$4B$6BQ4'22, Cash and equivalents: $103MQ4'22, Long-term debt: $4.7BQ4'22Q1'23, Cash and equivalents: $110MQ1'23, Long-term debt: $4.7BQ1'23Q2'23, Cash and equivalents: $79MQ2'23, Long-term debt: $4.6BQ2'23Q3'23, Cash and equivalents: $81MQ3'23, Long-term debt: $4.8BQ3'23Q4'23, Cash and equivalents: $119MQ4'23, Long-term debt: $4.8BQ4'23Q1'24, Cash and equivalents: $112MQ1'24, Long-term debt: $4.7BQ1'24Q2'24, Cash and equivalents: $129MQ2'24, Long-term debt: $4.4BQ2'24Q3'24, Cash and equivalents: $106MQ3'24, Long-term debt: $4.6BQ3'24Q4'24, Cash and equivalents: $126MQ4'24, Long-term debt: $4.5BQ4'24Q1'25, Cash and equivalents: $127MQ1'25, Long-term debt: $4.6BQ1'25Q2'25, Cash and equivalents: $138MQ2'25, Long-term debt: $4.5BQ2'25Q3'25, Cash and equivalents: $113MQ3'25, Long-term debt: $4.0BQ3'25Q4'25, Cash and equivalents: $138MQ4'25, Long-term debt: $4.0BQ4'25Q1'26, Cash and equivalents: $119MQ1'26, Long-term debt: $4.0BQ1'26Q2'26, Cash and equivalents: $139MQ2'26, Long-term debt: $4.1BQ2'26Q3'26, Cash and equivalents: $169MQ3'26, Long-term debt: $5.6BQ3'26$0$2B$4B$6BQ4'22, Cash and equivalents: $103MQ4'22, Long-term debt: $4.7BQ4'22Q1'23, Cash and equivalents: $110MQ1'23, Long-term debt: $4.7BQ1'23Q2'23, Cash and equivalents: $79MQ2'23, Long-term debt: $4.6BQ2'23Q3'23, Cash and equivalents: $81MQ3'23, Long-term debt: $4.8BQ3'23Q4'23, Cash and equivalents: $119MQ4'23, Long-term debt: $4.8BQ4'23Q1'24, Cash and equivalents: $112MQ1'24, Long-term debt: $4.7BQ1'24Q2'24, Cash and equivalents: $129MQ2'24, Long-term debt: $4.4BQ2'24Q3'24, Cash and equivalents: $106MQ3'24, Long-term debt: $4.6BQ3'24Q4'24, Cash and equivalents: $126MQ4'24, Long-term debt: $4.5BQ4'24Q1'25, Cash and equivalents: $127MQ1'25, Long-term debt: $4.6BQ1'25Q2'25, Cash and equivalents: $138MQ2'25, Long-term debt: $4.5BQ2'25Q3'25, Cash and equivalents: $113MQ3'25, Long-term debt: $4.0BQ3'25Q4'25, Cash and equivalents: $138MQ4'25, Long-term debt: $4.0BQ4'25Q1'26, Cash and equivalents: $119MQ1'26, Long-term debt: $4.0BQ1'26Q2'26, Cash and equivalents: $139MQ2'26, Long-term debt: $4.1BQ2'26Q3'26, Cash and equivalents: $169MQ3'26, Long-term debt: $5.6BQ3'26$0$2B$4B$6BQ4'22, Cash and equivalents: $103MQ4'22, Long-term debt: $4.7BQ1'23, Cash and equivalents: $110MQ1'23, Long-term debt: $4.7BQ1'23Q2'23, Cash and equivalents: $79MQ2'23, Long-term debt: $4.6BQ3'23, Cash and equivalents: $81MQ3'23, Long-term debt: $4.8BQ3'23Q4'23, Cash and equivalents: $119MQ4'23, Long-term debt: $4.8BQ1'24, Cash and equivalents: $112MQ1'24, Long-term debt: $4.7BQ1'24Q2'24, Cash and equivalents: $129MQ2'24, Long-term debt: $4.4BQ3'24, Cash and equivalents: $106MQ3'24, Long-term debt: $4.6BQ3'24Q4'24, Cash and equivalents: $126MQ4'24, Long-term debt: $4.5BQ1'25, Cash and equivalents: $127MQ1'25, Long-term debt: $4.6BQ1'25Q2'25, Cash and equivalents: $138MQ2'25, Long-term debt: $4.5BQ3'25, Cash and equivalents: $113MQ3'25, Long-term debt: $4.0BQ3'25Q4'25, Cash and equivalents: $138MQ4'25, Long-term debt: $4.0BQ1'26, Cash and equivalents: $119MQ1'26, Long-term debt: $4.0BQ1'26Q2'26, Cash and equivalents: $139MQ2'26, Long-term debt: $4.1BQ3'26, Cash and equivalents: $169MQ3'26, Long-term debt: $5.6BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Universal Health Services, Inc. Class B income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 26, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue4,7334,6384,4954,4864,4954,2844,1004,114+5.3%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative—————————
Operating income454517503517522500455472−12.9%
Other income (expense)162310614866+15.5%
Pretax income414479469581497473420438−16.7%
Income tax10111511013411811199101−14.6%
Net income309358349446373353317332−17.2%
Diluted EPS ($)5.225.985.65—5.865.434.80—−10.9%
Diluted shares (millions)596062—646566——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Universal Health Services, Inc. Class B balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 26, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents169139119138113138127126+49.5%
Short-term investments—————————
Total current assets3,6803,6793,5003,4083,2582,9903,0772,816+13.0%
Total assets17,18615,93515,68115,52815,34414,98614,87514,470+12.0%
Total current liabilities2,6873,2983,2443,2403,1592,3172,3302,210−14.9%
Long-term debt5,6284,0803,9524,0043,9514,5424,6094,464+42.4%
Total liabilities—————————
Stockholders’ equity7,5977,5147,4657,2767,1707,0306,7866,666+6.0%
Shares outstanding (millions)—————————

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

Universal Health Services, Inc. Class B cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 26, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow637443402575381549360658+67.2%
Capital expenditures215228217281229266239246−6.1%
Free cash flow (CFO − capex)422216184293152283121412+177.8%
Depreciation and amortization175167155163155152148147+12.8%
Share repurchases245321164352237155223250+3.3%
Dividends paid1212131212131413−5.4%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 25, 2026.

Income statement

Universal Health Services, Inc. Class B income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 26, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Dec 31, 2022filed Feb 27, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 25, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 27, 2019FY2017ended Dec 31, 2017filed Feb 28, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 25, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Aug 9, 2010FY2008ended Dec 31, 2008filed Aug 9, 2010
Revenue17,36515,82814,28213,39912,64211,55911,37810,77210,4109,7669,0438,2057,3686,9616,7604,9005,2025,022
Cost of revenue——————————————————
Gross profit——————————————————
Research and development——————————————————
Selling, general and administrative——————————————————
Operating income1,9941,6821,1751,0041,3631,3581,2161,1751,2801,2811,2591,0631,015943897506521410
Other income (expense)1342(28)(10)140131400————————
Pretax income1,9721,4989408661,2931,2521,0661,0351,1351,1561,146930869764696428475357
Income tax461335221209306299239237364409395325315275247152170123
Net income1,4891,142718676992944815780752702681545511443398230260199
Diluted EPS ($)23.1016.8210.239.1411.8210.999.138.317.817.146.765.425.144.534.042.342.641.96
Diluted shares (millions)646870748486899496981011019998999898101

Balance sheet

Universal Health Services, Inc. Class B balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 26, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Dec 31, 2022filed Feb 27, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 25, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 27, 2019FY2017ended Dec 31, 2017filed Feb 28, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 25, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Aug 9, 2010FY2008ended Dec 31, 2008filed Aug 9, 2010
Cash and equivalents1381261191031151,22461105743461321723412995
Short-term investments——————————————————
Total current assets3,4082,8162,8112,5372,2643,2821,9161,9381,7981,6811,7181,6151,4321,4071,3651,331796—
Total assets15,52814,47013,96813,49413,09413,47711,66811,26510,76210,3189,6158,9518,3128,2017,6657,5283,964—
Total current liabilities3,2402,2102,0131,9141,9842,4811,5631,4491,8481,3171,1001,1831,060894837826583—
Long-term debt4,0044,4644,7864,7274,1423,5243,8973,9353,4944,0303,3693,2103,2103,7273,6513,912956—
Total liabilities——————————————————
Stockholders’ equity7,2766,6666,1495,9216,0906,3175,5045,3894,9904,5334,2503,7363,2502,7132,2961,9791,751—
Shares outstanding (millions)——————————————————

Cash flow statement

Universal Health Services, Inc. Class B cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 25, 2026FY2024ended Dec 31, 2024filed Feb 26, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Dec 31, 2022filed Feb 27, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 25, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 27, 2019FY2017ended Dec 31, 2017filed Feb 28, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 25, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Aug 9, 2010FY2008ended Dec 31, 2008filed Aug 9, 2010
Operating cash flow1,8642,0671,2689968842,3601,4381,2751,2481,3341,0681,036884799711501541494
Capital expenditures1,015944743734856731634665558520379391358363286239380355
Free cash flow (CFO − capex)8491,123525262281,629804610690814689645526436425262162140
Depreciation and amortization619585568582533510490453448417399376337309296224205196
Share repurchases9686715478331,2212077713973643532101012719601263149
Dividends paid515355586617533738394030205819191716

Insider activity

Form 4 filings by officers, directors and 10% owners, November 9, 2024 to November 9, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$980K
4 sales by 2 insiders; officers and directors $980K

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerotherindirect13,963$0.00—0May 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerother13,963$0.00—2MMay 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerotherindirect9,418$0.00—0May 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerother9,418$0.00—2MMay 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerother9,418$0.00—2MMay 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerotherindirect14,163$0.00—10,132May 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerother14,163$0.00—2MMay 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerother14,163$0.00—2MMay 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerother14,163$0.00—2MMay 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerother50,990$0.00—2MMay 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerotherindirect50,990$0.00—50,990May 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerother25,495$0.00—2MMay 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerotherindirect25,495$0.00—25,495May 29, 2026
May 27, 2026Miller Alan BExecutive Chairman, Director, 10% ownerother25,495$0.00—2MMay 29, 2026
May 20, 2026Chen-Langenmayr NinaDirectoraward1,217$0.00—4,267May 21, 2026
May 20, 2026Sussman Elliot J MD MbaDirectoraward1,217$0.00—7,330May 21, 2026
May 20, 2026McDonnell Eileen C.Directoraward1,217$0.00—9,406May 21, 2026
May 20, 2026Singer Maria RudermanDirectoraward1,217$0.00—9,792May 21, 2026
May 20, 2026Nimetz Warren J.Directoraward1,217$0.00—9,698May 21, 2026
Mar 26, 2026Sim Edward HExecutive Vice Presidentaward6,404$0.00—24,790Mar 30, 2026
Mar 26, 2026Peterson Matthew JayExecutive Vice President, UHSaward5,627$0.00—31,984Mar 30, 2026
Mar 26, 2026Miller Alan BExecutive Chairman, Director, 10% owneraward14,153$0.00—2MMar 30, 2026
Mar 26, 2026Miller Marc DPresident and CEO, Directoraward29,715$0.00—388,621Mar 30, 2026
Mar 26, 2026Filton SteveExecutive Vice President & CFOaward6,850$0.00—144,715Mar 30, 2026
Mar 26, 2026Peterson Matthew JayExecutive Vice President, UHSaward5,627$0.00—31,984Mar 30, 2026

Full insider history for Universal Health Services, Inc. Class B, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
UNIVERSAL HEALTH SERVICES, INC., CIK 352915 on EDGAR
Extract generated
November 8, 2026
Withheld
5 line-years whose four quarters do not sum to the filed year: revenue FY2010, capex FY2011, depreciation amortization FY2011, depreciation amortization FY2012, revenue FY2013
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: HealthCareOrganizationRevenue, RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNet
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: not filed
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): not filed

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 8, 2026.

JSON file
/data/financials/UHS.json